Figures show ctDNA analysis and radiomic models improve risk assessment and prognostic factors in localized lung cancer, suggesting enhanced patient outcomes.
Figures showing the CONSORT diagram, clonal hematopoiesis prevalence, the SNV score model, mid-chemoradiation ctDNA analysis, radiomic model robustness, pre-chemoradiation prognostic factors, association of clonal hematopoiesis with outcomes, and association of the CIRI-LCRT model with progression-free survival.
No takes yet. Share an insight, caveat, or question.
Moding et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: